Summary

France In Vitro Diagnostics Market Summary

The France in vitro diagnostics market size was estimated at USD 4.37 billion in 2025 and is projected to reach USD 6.93 billion by 2030, growing at a CAGR of 5.86% from 2026 to 2033. Some of the key growth factors driving the market growth include the increasing prevalence of chronic and infectious diseases, advancements in diagnostic technologies, and the shift toward value-based healthcare emphasizing early detection and preventive care.

The growth of the market is attributed to the rising global demand for accurate, rapid, and personalized diagnostic solutions. The integration of digital health, AI, and data analytics into diagnostic platforms enhances test accuracy and clinical decision-making. In addition, the expansion of point-of-care testing, personalized medicine, and emerging markets, coupled with heightened pandemic preparedness, continues to drive market penetration, creating significant opportunities for industry stakeholders.

The France in vitro diagnostics industry is evolving rapidly, driven by technological advancements, rising disease prevalence, and government initiatives to strengthen healthcare infrastructure. Major global players, including Roche, Thermo Fisher Scientific, Qiagen, Danaher, and Hologic, have established a strong presence in France, continuously expanding their molecular diagnostics portfolios with real-time PCR systems and high-throughput sequencing tools.

Furthermore, the French molecular diagnostic market would thus be directly impacted by this acquisition, as companies expand their capabilities and presence in this growing sector. In January 2025, bioM?rieux acquired SpinChip Diagnostics ASA (SpinChip). This small benchtop analyzer is designed for near-patient testing, delivering high-sensitivity results from whole blood samples within 10 minutes-a level of performance previously available only in laboratory settings.

France In Vitro Diagnostics Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the France in vitro diagnostics market report based on products, technology, application, test location, and end-use:

? Product Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
? Instruments
? Reagents
? Software
? Technology Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
? Immunoassay
o Instruments
o Reagents
o Others
? Hematology
o Instruments
o Reagents
o Others
? Clinical Chemistry
o Instruments
o Reagents
o Others
? Molecular Diagnostics
o Instruments
o Reagents
o Others
? Coagulation
o Instruments
o Reagents
o Others
? Microbiology
o Instruments
o Reagents
o Others
? Others
o Instruments
o Reagents
o Others
? Application Outlook (Revenue, USD Billion, 2021 - 2033)
? Infectious Diseases
? Diabetes
? Oncology
? Cardiology
? Nephrology
? Autoimmune Diseases
? Drug Testing
? Other applications
? Test Location Outlook (Revenue, USD Billion, 2021 - 2033)
? Point of Care
? Home-care
? Others
? End-use Outlook (Revenue, USD Billion, 2021 - 2033) (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
? Hospitals
o Public
o Private
? Laboratory
o Public
o Private
? Others

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. Test Location
1.2.5. End Use
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.7. Details of primary research
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity flow analysis (Model 1)
1.9.1.1. Approach 1: Commodity flow approach
1.9.2. Volume price analysis (Model 2)
1.9.2.1. Approach 2: Volume price analysis
1.10. Research Scope and Assumptions
1.10.1. List of Secondary Sources
1.10.2. List of Primary Sources
1.10.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. France In Vitro Diagnostics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. High public healthcare spending & strong per-capita health investment
3.2.1.2. Increased national lab capacity, testing awareness and volumes
3.2.1.3. Government support for innovative diagnostics
3.2.1.4. Improved validation and reimbursement pathways for new IVDs.
3.2.2. Market Restraints Analysis
3.2.2.1. Pricing pressure and tight cost containment measures
3.2.2.2. Regulatory complexity and IVDR-related burden
3.2.2.3. Limited volume growth for conventional IVD tests
3.2.3. Market Opportunity Analysis
3.2.4. Supply Chain Analysis
3.2.5. Distribution Channel
3.2.5.1. Direct Sales
3.2.5.2. Distributors Network
3.2.5.3. E-commerce and Online Platforms
3.2.5.4. Major Distributors
3.3. France In Vitro Diagnostics Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Legal landscape
3.4. Reimbursement Overview of IVDs and LDTs
3.5. Pricing Analysis
Chapter 4. France In Vitro Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. France In Vitro Diagnostics Market: Product Movement Analysis, 2025 & 2033 (USD Billion)
4.3. Instruments
4.3.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
4.4. Reagents
4.4.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
4.5. Services
4.5.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 5. France In Vitro Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. France In Vitro Diagnostics Market: Technology Movement Analysis, 2025 & 2033 (USD Billion)
5.3. Immunoassay
5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.3.2. Instruments
5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Units)
5.3.3. Reagents
5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.3.4. Services
5.3.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.4. Hematology
5.4.1. Hematology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.4.2. Instruments
5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.4.3. Reagents
5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.4.4. Services
5.4.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.5. Clinical Chemistry
5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.5.2. Instruments
5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.5.3. Reagents
5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.5.4. Services
5.5.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.6. Molecular Diagnostics
5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.6.2. Instruments
5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.6.3. Reagents
5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.6.4. Services
5.6.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.7. Coagulation
5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.7.2. Instruments
5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.7.3. Reagents
5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.7.4. Services
5.7.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.8. Microbiology
5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.8.2. Instruments
5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.8.3. Reagents
5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.8.4. Services
5.8.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
5.9.2. Instruments
5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands)
5.9.3. Reagents
5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Reagents, Number of Tests in Million)
5.9.4. Services
5.9.4.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 6. France In Vitro Diagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. France In Vitro Diagnostics Market: Application Movement Analysis, 2025 & 2033 (USD Billion)
6.3. Infectious Disease
6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.4. Diabetes
6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.5. Oncology/Cancer
6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.6. Cardiology
6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.7. Nephrology
6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.8. Autoimmune Diseases
6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.9. Drug Testing
6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
6.10. Others
6.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 7. France In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. France In Vitro Diagnostics Market: Test Location Movement Analysis, 2025 & 2033 (USD Billion)
7.3. Point of Care
7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.4. Home-care
7.4.1. Home-care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
7.5. Others
7.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 8. France In Vitro Diagnostics Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. France In Vitro Diagnostics Market: End Use Movement Analysis, 2025 & 2033 (USD Billion)
8.3. Hospitals
8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.3.2. Private
8.3.2.1. Private Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.3.3. Public
8.3.3.1. Public Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.4. Laboratory
8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.4.2. Private
8.4.2.1. Private Labs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.4.3. Public
8.4.3.1. Public Labs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
8.5. Others
8.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Global and local Company Market Share Analysis, 2025
9.4. Company Heat Map Analysis
9.5. Strategy Mapping
9.5.1. Expansion
9.5.2. Mergers & Acquisition
9.5.3. Partnerships & Collaborations
9.5.4. New Product Launches
9.5.5. Research And Development
9.6. Company Profiles
9.6.1. Euroblo Scientific
9.6.1.1. Participant’s Overview
9.6.1.2. Financial Performance
9.6.1.3. Product Benchmarking
9.6.1.4. Recent Developments
9.6.2. Servibio
9.6.2.1. Participant’s Overview
9.6.2.2. Financial Performance
9.6.2.3. Product Benchmarking
9.6.2.4. Recent Developments
9.6.3. CliniSciences
9.6.3.1. Participant’s Overview
9.6.3.2. Financial Performance
9.6.3.3. Product Benchmarking
9.6.3.4. Recent Developments
9.6.4. Avantor, Inc.
9.6.4.1. Participant’s Overview
9.6.4.2. Financial Performance
9.6.4.3. Product Benchmarking
9.6.4.4. Recent Developments
9.6.5. QIAGEN
9.6.5.1. Participant’s Overview
9.6.5.2. Financial Performance
9.6.5.3. Product Benchmarking
9.6.5.4. Recent Developments
9.6.6. BD
9.6.6.1. Participant’s Overview
9.6.6.2. Financial Performance
9.6.6.3. Product Benchmarking
9.6.6.4. Recent Developments
9.6.7. bioMerieux SA
9.6.7.1. Participant’s Overview
9.6.7.2. Financial Performance
9.6.7.3. Product Benchmarking
9.6.7.4. Recent Developments
9.6.8. F. Hoffmann-La Roche Ltd.
9.6.8.1. Participant’s Overview
9.6.8.2. Financial Performance
9.6.8.3. Product Benchmarking
9.6.8.4. Recent Developments
9.6.9. QuidelOrtho Corporation
9.6.9.1. Participant’s Overview
9.6.9.2. Financial Performance
9.6.9.3. Product Benchmarking
9.6.9.4. Recent Developments
9.6.10. Abbott
9.6.10.1. Participant’s Overview
9.6.10.2. Financial Performance
9.6.10.3. Product Benchmarking
9.6.10.4. Recent Developments
9.6.11. Agilent Technologies, Inc.
9.6.11.1. Participant’s Overview
9.6.11.2. Financial Performance
9.6.11.3. Product Benchmarking
9.6.11.4. Recent Developments
9.6.12. Siemens Healthineers AG
9.6.12.1. Participant’s Overview
9.6.12.2. Financial Performance
9.6.12.3. Product Benchmarking
9.6.12.4. Recent Developments
9.6.13. Bio-Rad Laboratories, Inc.
9.6.13.1. Participant’s Overview
9.6.13.2. Financial Performance
9.6.13.3. Product Benchmarking
9.6.13.4. Recent Developments
9.6.14. Danaher
9.6.14.1. Participant’s Overview
9.6.14.2. Financial Performance
9.6.14.3. Product Benchmarking
9.6.14.4. Recent Developments
9.6.15. Sysmex Corporation
9.6.15.1. Participant’s Overview
9.6.15.2. Financial Performance
9.6.15.3. Product Benchmarking
9.6.15.4. Recent Developments
9.6.16. Charles River Laboratories
9.6.16.1. Participant’s Overview
9.6.16.2. Financial Performance
9.6.16.3. Product Benchmarking
9.6.16.4. Recent Developments
9.6.17. Quest Diagnostics Incorporated
9.6.17.1. Participant’s Overview
9.6.17.2. Financial Performance
9.6.17.3. Product Benchmarking
9.6.17.4. Recent Developments
9.6.18. Novacyt Group
9.6.18.1. Participant’s Overview
9.6.18.2. Financial Performance
9.6.18.3. Product Benchmarking
9.6.18.4. Recent Developments
9.6.19. Acobiom
9.6.19.1. Participant’s Overview
9.6.19.2. Financial Performance
9.6.19.3. Product Benchmarking
9.6.19.4. Recent Developments
9.6.20. Poly-Dtech
9.6.20.1. Participant’s Overview
9.6.20.2. Financial Performance
9.6.20.3. Product Benchmarking
9.6.20.4. Recent Developments
9.6.21. Biosynex.
9.6.21.1. Participant’s Overview
9.6.21.2. Financial Performance
9.6.21.3. Product Benchmarking
9.6.21.4. Recent Developments

ページTOPに戻る

List of Tables/Graphs

List of Tables

Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Regulatory Framework
Table 4. France In Vitro Diagnostics Market, By Region, 2021 - 2033 (USD Billion), (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 5. France In Vitro Diagnostics Market, By Product, 2021 - 2033 (USD Billion, Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million
Table 6. France In Vitro Diagnostics Market, By Technology, 2021 - 2033 (USD Billion), (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 7. France In Vitro Diagnostics Market, By Application, 2021 - 2033 (USD billion)
Table 8. France In Vitro Diagnostics Market, By End Use, 2021 - 2033 (USD Billion), (Volume, Number of Instruments, in Thousands, Volume, Reagents, Number of Tests in Million)
Table 9. France In Vitro Diagnostics Market, By Test Location, 2021 - 2033 (USD Billion)List of Figures

Fig. 1 France In Vitro Diagnostics Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Data Triangulation Techniques
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value-Chain-Based Sizing & Forecasting
Fig. 7 QFD Modeling For Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 In Vitro Diagnostic Market Snapshot
Fig. 10 Parent Market Outlook, 2025
Fig. 11 In Vitro Diagnostic Market Driver Impact
Fig. 12 Global Elderly Population
Fig. 13 New Cancer Cases By Year
Fig. 14 In Vitro Diagnostic Market Restraint Impact
Fig. 15 Market Entry Strategy
Fig. 16 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
Fig. 17 Porter’s Five Forces Analysis
Fig. 18 France IVD Market: Product Outlook And Key Takeaways
Fig. 19 France IVD Market: Products Movement Analysis
Fig. 20 Instruments Market Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Fig. 21 Reagents Market Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Fig. 22 Services Market Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 23 France IVD Market: Technology Outlook And Key Takeaways
Fig. 24 IVD Market: Technology Movement Analysis
Fig. 25 Immunoassay Market Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Fig. 26 Instruments Market For Immunoassay Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands)
Fig. 27 Reagents Market For Immunoassay Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Reagents, Number Of Tests In Million)
Fig. 28 Services Market For Immunoassay Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 29 Hematology Market Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Fig. 30 Instruments Market For Hematology Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands)
Fig. 31 Reagents Market For Hematology Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Reagents, Number Of Tests In Million)
Fig. 32 Services Market For Hematology Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 33 Clinical Chemistry Market Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Fig. 34 Instruments Market For Clinical Chemistry Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands)
Fig. 35 Reagents Market For Clinical Chemistry Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Reagents, Number Of Tests In Million)
Fig. 36 Services Market For Clinical Chemistry Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 37 Molecular Diagnostics Market Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Fig. 38 Instruments Market For Molecular Diagnostics Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands)
Fig. 39 Reagents Market For Molecular Diagnostics Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Reagents, Number Of Tests In Million)
Fig. 40 Services Market For Molecular Diagnostics Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 41 Coagulation Market Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Fig. 42 Instruments Market For Coagulation Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands)
Fig. 43 Reagents Market For Coagulation Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Reagents, Number Of Tests In Million)
Fig. 44 Services Market For Coagulation Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 45 Microbiology Market Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Fig. 46 Instruments Market For Microbiology Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands)
Fig. 47 Reagents Market For Microbiology Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Reagents, Number Of Tests In Million)
Fig. 48 Services Market For Microbiology Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 49 Others Market Estimates And Forecast, 2021 - 2033 (USD Billion)Billion, Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million
Fig. 50 Instruments Others Market Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands)
Fig. 51 Reagents Others Market Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Reagents, Number Of Tests In Million)
Fig. 52 Services Market For Other Technology Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 53 France IVD Market: Application Outlook And Key Takeaways
Fig. 54 France IVD Market: Application Movement Analysis
Fig. 55 Infectious Diseases Market Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 56 Diabetes Market Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 57 Oncology Market Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 58 Cardiology Market Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 59 Nephrology Market Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 60 Autoimmune Diseases Market Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 61 Drug Testing Market Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 62 Other Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
Fig. 63 France IVD Market: End-Use Outlook And Key Takeaways
Fig. 64 IVD Treatment Market: End-Use Movement Analysis
Fig. 65 Hospitals Market Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Fig. 66 Laboratory Market Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Fig. 67 Other Market Estimates And Forecast, 2021 - 2033 (USD Billion), (Volume, Number Of Instruments, In Thousands, Volume, Reagents, Number Of Tests In Million)
Fig. 68 France IVD Market: Test Location Outlook And Key Takeaways
Fig. 69 IVD Treatment Market: Test Location Movement Analysis
Fig. 70 Point-Of-Care Market Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 71 Homecare Market Estimates And Forecast, 2021 - 2033 (USD Billion)
Fig. 72 Other Market Estimates And Forecasts, 2021 - 2033 (USD Billion)